Article Details

Why AstraZeneca Is Buying CinCor Pharma For $1.8 Billion (AZN) (CINC) - Pulse 2.0

Retrieved on: 2023-01-09 20:11:48

Tags for this article:

Click the tags to see associated articles and topics

Why AstraZeneca Is Buying CinCor Pharma For $1.8 Billion (AZN) (CINC) - Pulse 2.0. View article details on hiswai:

Excerpt

This deal would bolster AstraZeneca's portfolio of heart and kidney drugs. CinCor's experimental therapy baxdrostat has been a strong selling point ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up